ALLO and ALCLS Related Headlines

Go Back

Dec 15, 2025 05:40PM Allogene retains control of cancer therapy after arbitration ruling
Dec 15, 2025 05:39PM Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis

ALLO and ALCLS Related Press Releases

Go Back

Dec 15, 2025 05:39PM Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis

ALLO and ALCLS Related SEC Filings

Go Back